Henry Levy serves as the President of Life Sciences and Healthcare at Clarivate Plc, a global leader in providing trusted information and analytics to accelerate the pace of innovation. With a robust background in the life sciences and healthcare sectors, Levy has been instrumental in driving Clarivate's strategic initiatives and fostering growth within these critical industries. His leadership has been pivotal in enhancing the company's offerings, which include advanced analytics, data-driven insights, and innovative solutions that support drug discovery, development, and commercialization. Prior to joining Clarivate, Levy held several high-profile positions that have shaped his expertise in the field. He previously served as the CEO of MediMedia Managed Markets, where he successfully led the company through a period of significant growth and transformation. His career also includes key roles at Dendrite International and IMS Health, where he honed his skills in strategic planning and business development. Levy's educational background includes a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania, providing him with a strong foundation in business and finance. In his current role at Clarivate, Levy is responsible for overseeing the company's life sciences and healthcare portfolio, ensuring that it continues to meet the evolving needs of its clients. Under his guidance, Clarivate has expanded its capabilities in areas such as real-world evidence, regulatory solutions, and clinical trial optimization. His vision for the company is to remain at the forefront of innovation, delivering solutions that not only enhance efficiency but also contribute to better patient outcomes. Levy's leadership is characterized by a commitment to excellence and a passion for advancing the life sciences and healthcare sectors.